Abstract
96 Incidence of nephrotoxicity associated with concomitant colistimethate and vancomycin use in cystic fibrosis patients M. Adeola1, A. Coralic1, S. Hart1, T.L. Barto2, M. Katz2,3. 1The Methodist Hospital, Pharmacy, Houston, United States; 2Baylor College of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Houston, United States; 3Texas Children’s Hospital Pavilion for Women, Houston, United States
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
